A patient administers interferon beta-1a SQ (Rebif) 22 mcg/0.5 mL 3 times each week. the patient calls the nurse to report unrelieved itching and erythema at the injection site, despite the use of topical hydrocortisone for several weeks. What will the nurse tell this patient to do?